Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

Isodiol International Inc.

Isodiol produces CBD products made from non-GMO hemp, ensuring that each batch is third-party tested and free of pesticides and heavy metals. Isodiol's offerings include products that are THC-free and manufactured in compliance with the 2018 Farm Bill.

Isodiol

Isodiol International, Inc | 1,357 followers on LinkedIn. Live Healthier, Naturally | Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of consumer products.

We have pioneered many firsts for the cannabis industry, including commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products and most recently received approval as having the first CBD designated as an Active Pharmaceutical Ingredient as was announced April 26, 2018.

Our growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding our phytoceutical portfolio and we will continue to aggressively expand internationally into Latin America, Asia and Europe.

Commercial Operations - Isodiol International, Inc

Fernando Blanco Armendáriz

	Mar '19
revenue	16.65M -
cost of revenue	20.71M -
gross profit	-4.05M -
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses	25.09M -
research and development expenses	80.50K -
other expenses	-0.00 -
cost and expenses	45.88M -
operating expenses	25.17M -
interest expense	4.47M -
ebitda	-27.69M -
operating income	-29.23M -
depreciation and amortization	1.54M -
total other income expenses net	-61.28M -
income before tax	-90.51M -
income tax expense	-225.38K -
net income	-90.28M -
weighted average shs out	38.40M -
weighted average shs out dil	38.40M -
eps	-2.35 -
epsdiluted	-2.35 -

ISOL

COM:ISODIOL

Isodiol

Market Cap

135.44K

Beta: -

Volume Today

500

Avg: -

Preview